In the treatment of hypertension, angiotensin-converting enzyme (ACE) inhibitors, Ang II type 1 receptor (AT1R) antagonists, and mineralocorticoid receptor antagonists are cornerstones in blocking RAS. Here, AGTR1 is linked to hypertensive disorder.